Page 6 - 《中国药房》2023年4期
P. 6
Efficacy and safety of parecoxib versus ketorolac tromethamine for perioperative analgesia: a systematic review
⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅ LIN Mao,HU Zhiqiang,CHEN Ya,XIAO Hongtao,JIANG Qian (476)
Meta-analysis of the efficacy and safety of immune checkpoint inhibitors in the treatment of metastatic colorectal
cancer ⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅ CHEN Wei,CHEN Jiayi,LI Ling,YU Junxian (482)
Discussion on the concept of collaboration between clinical pharmacists and physicians in China ⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅
⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅ WANG Chenyu,HUANG Yuankai,XI Xiaoyu (487)
Establishment and application of path-based management mode of 5-HT3 receptor antagonists in chemotherapy
patients ⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅ GAO Lu,LI Jing,ZHOU Xiao,HUANG Yuan,YU Lin,SONG Huizhu,YANG Yuhua (493)
Research progress of thrombolytic drugs for acute ischemic stroke ⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅ KONG Weilin,YANG Qingwu (497)
Application progress of parallel artificial membrane permeation assay model in drug permeability screening of
transdermal drug delivery system ⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅ SONG Sankong,BAI Yinliang,LIANG Jiandi (502)
Research progress and clinical application of liposomal drug delivery system ⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅
⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅⋅ GU Wenrui,YANG Ya,MA Huan,XIA Peiyuan (508)
CHINA PHARMACY (Semimonthly)
Founded in January 1990
Vol.34, No.4, Feb. 2023
Total No.742 Published on Feb. 28,2023
Responsible Institution Phone
National Health Commission,P.R. China +86-23-63830521;+86-23-63830907;+86-23-68586727;
Sponsored by +86-23-68586827
Chinese Hospital Association E-mail
Chongqing University Cancer Hospital info@china-pharmacy.com
Edited by Website
China Pharmacy Editorial and Publishing Center http://www.china-pharmacy.com
Director of Editorial Commission Online Submission
LI Linkang http://user.china-pharmacy.com
Executive Deputy Director of Editorial Commission Printed by
WU Yongzhong Chongqing Changhong Printing Co., Ltd.
Chief of Center Distributed by
ZOU Xiaoyong China: Chongqing Post Offices(Code No.78-33)
Editor-in-Chief Overseas: China International Book Trading Corporation
HU Xin
Vice Editor-in-Chief (Code No.4703SM)
LENG Huaiming Subscription Rates
Chief Editor CNY 15 per issue;CNY 360 per annum
ZHANG Jian CSSN ISSN 1001-0408
Published by CN 50-1055/R
China Pharmacy Editorial Department CODEN
Postal Address ZYHAA4
129 Daping Main Street,Yuzhong District,Chongqing Perennial Legal Counsel
400042,China Chongqing Huali Wantao Law Firm